Article type
Abstract
Background: Gynecological cancers, constituting 15% of new cancer diagnoses in women globally, lack evidence-based perioperative care guidelines despite the implementation of Enhanced Recovery After Surgery (ERAS) programs, which have proven effective in non-gynecological settings.
Objective: To assess the benefits and adverse effects of perioperative Enhanced Recovery After Surgery (ERAS) programs in gynaecological cancer care, focusing on postoperative hospital stay duration, complications, mortality, readmission rates, organ functions, quality of life, patient satisfaction, and economic impacts.
Methods: We will retrieve several English and Chinese electronic database, including Web of Science, PubMed, The Cochrane Library, The Campbell Library, Embase, CNKI, CBM, Wanfang and Weipu. We will include randomized controlled trials (RCTs) that compare ERAS programs for perioperative care in women with gynaecological cancer to traditional care.
Results: This study is ongoing, and it will be completed before April 2024.
Conclusion: Despite the proven benefits of ERAS in other fields, there is a lack of specific, evidence-based guidelines for its application in gynaecological cancer care. This updated review seeks to fill that gap by evaluating the effectiveness of ERAS programs on recovery, complications, and other key patient outcomes.
Objective: To assess the benefits and adverse effects of perioperative Enhanced Recovery After Surgery (ERAS) programs in gynaecological cancer care, focusing on postoperative hospital stay duration, complications, mortality, readmission rates, organ functions, quality of life, patient satisfaction, and economic impacts.
Methods: We will retrieve several English and Chinese electronic database, including Web of Science, PubMed, The Cochrane Library, The Campbell Library, Embase, CNKI, CBM, Wanfang and Weipu. We will include randomized controlled trials (RCTs) that compare ERAS programs for perioperative care in women with gynaecological cancer to traditional care.
Results: This study is ongoing, and it will be completed before April 2024.
Conclusion: Despite the proven benefits of ERAS in other fields, there is a lack of specific, evidence-based guidelines for its application in gynaecological cancer care. This updated review seeks to fill that gap by evaluating the effectiveness of ERAS programs on recovery, complications, and other key patient outcomes.